title: Microbiology specimens obtained at the time of surgical lung biopsy for interstitial lung disease: clinical yield and cost analysis.
abstract: OBJECTIVE
  In efforts to obtain complete results, current practice in surgical lung biopsy (LB) for interstitial lung disease (ILD) recommends sending lung tissue samples for bacterial, mycobacterial, fungal, and viral cultures. This study assesses the value of this practice by evaluating the microbiology findings obtained from LB for ILD and their associated costs.
  
  
  METHODS
  A total of 296 consecutive patients (140 women, 156 men, median age=61 years) underwent LB for ILD from 2002 to 2009. All had lung tissue sent for microbiology examination. Microbiology results and resultant changes in patient management were analyzed retrospectively. A cost analysis was performed based upon nominal hospital charges adjusted on current inflation rates. Cost data included cultures, stains, smears, direct fluorescent antibody studies, and microbiologist consulting fees.
  
  
  RESULTS
  As many as 25 patients (8.4%) underwent open LB and 271 (91.6%) underwent thoracoscopic LB. A total of 592 specimens were assessed (range 1-4 per patient). The most common pathologic diagnoses were idiopathic pulmonary fibrosis in 122 (41.2%), cryptogenic organizing pneumonia in 31 (10.5%), and respiratory bronchiolitis ILD in 16 (5.4%). Microbiology testing was negative in 174 patients (58.8%). A total of 118 of 122 (96.7%) positive results were clinically considered to be contaminants and resulted in no change in clinical management. The most common contaminants were Propionibacterium acnes (38 patients; 31%) and Penicillium fungus (16 patients; 13%). In only four patients (1.4%), the organism cultured (Nocardia one, Histoplasma one, and Aspergillus fumigatus two) resulted in a change in clinical management. The cost of microbiology studies per specimen was $984 (€709), with a total cost for the study cohort being $582,000 (€420,000).
  
  
  CONCLUSIONS
  The yield and impact on clinical management of microbiology specimens from LB for ILD is very low. Its routine use in LB is questionable. We suggest it should be limited to those cases of ILD with a high suspicion of infection. Substantial cost savings are possible with this change in clinical practice.
authors: Division of General Thoracic Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905,  USA.
authors: Juan J
authors: JJ
authors: Fibla
authors: Alessandro
authors: A
authors: Brunelli
authors: Mark S
authors: MS
authors: Allen
authors: Dennis
authors: D
authors: Wigle
authors: Robert
authors: R
authors: Shen
authors: Francis
authors: F
authors: Nichols
authors: Claude
authors: C
authors: Deschamps
authors: Stephen D
authors: SD
authors: Cassivi
references: Ann Thorac Surg. 2005 Jun;79(6):2172-9
references: 15919344
references: Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):646-64
references: 10673212
references: Curr Opin Pulm Med. 2010 Sep;16(5):489-95
references: 20592601
references: Mayo Clin Proc. 2007 Aug;82(8):976-86
references: 17673067
references: Eur J Cardiothorac Surg. 2008 May;33(5):781-5
references: 18356069
references: Eur J Cardiothorac Surg. 1997 Jan;11(1):22-4, 25-6
references: 9030785
references: Ann Thorac Surg. 1998 Jan;65(1):198-202
references: 9456117
references: Clin Chest Med. 1982 Sep;3(3):457-73
references: 6751668
references: Ann Thorac Surg. 1980 Nov;30(5):411-26
references: 7436611
references: Eur J Cardiothorac Surg. 2007 Jun;31(6):1115-9
references: 17418586
references: J Thorac Cardiovasc Surg. 2005 May;129(5):984-90
references: 15867770
references: Eur J Cardiothorac Surg. 2002 Apr;21(4):621-6; discussion 626
references: 11932157
references: Eur J Cardiothorac Surg. 1999 Dec;16(6):624-7
references: 10647831